Windward Bio Group AG
Windward Bio Group AG
Your view on WWB
Overview
What the company does, where it operates, and who runs it.
About Windward Bio Group AG
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Luca Santarelli
- Headquarters
- Aeschenplatz 6, Basel, BS, CH
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Luca Santarelli
- Headquarters
- Aeschenplatz 6, Basel, BS, CH
Operates as a holding company whose subsidiaries develops and commercializes therapeutics
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Windward Bio Group AG from FRC's valuation model, read against the market price. WWB last traded at $22.64; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Windward Bio Group AG. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Windward Bio Group AG. Windward Bio Group AG does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Windward Bio Group AG. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Windward Bio Group AG. Windward Bio Group AG has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
More Medical - Pharmaceuticals companies
Market cap
- OMHEOmni Health, Inc.OTC$29,291
- ORXOFOrexo AB (publ)OTC$111M
- ORXOYOrexo AB (publ)OTC$103M
- OVITOncoVista Innovative Therapies, Inc.OTC$2,356
- OXIHFOxford Investments Holdings Inc.OTC$71,958
- PAVSParanovus Entertainment Technology Ltd.NASDAQ$2M
- PBHPrestige Consumer Healthcare Inc.NYSE$2.4B
- PKBFFPeakBirch Commerce Inc.OTC$545M
- PLWYPeoplesway.com Inc.OTC$1,508
- PNDHFPond Technologies Holdings Inc.OTC$684,738
- PNPLPineapple, Inc.OTC$6M
- POMPOMDOCTOR LtdNASDAQ$14M
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Windward Bio Group AG, and how their positions are changing. At a $1.31B market value, institutional positions materially move Windward Bio Group AG's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Windward Bio Group AG executives and directors. Shares of Windward Bio Group AG have traded between $18.35 and $33.99 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Windward Bio Group AG. Windward Bio Group AG is a $1.31B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Windward Bio Group AG. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Windward Bio Group AG. Coverage tracks Windward Bio Group AG within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Windward Bio Group AG.